Home > > > Cannabidiol (CBD) Market Outlook: Pharmaceutical and Personal Care Applications

Cannabidiol (CBD) Market Outlook: Pharmaceutical and Personal Care Applications

Author : ashlesha more | Published On : 28 Oct 2026

The global cannabidiol (CBD) market was valued at USD 9.95 billion in 2025 and is projected to increase from USD 11.55 billion in 2026 to USD 38.07 billion by 2034, registering a compound annual growth rate (CAGR) of 16.08% during the forecast period from 2026 to 2034. North America held the largest regional market share at 42% in 2025, while Europe is expected to record the fastest regional growth, with a projected CAGR of 17.8%.

Cannabidiol is a naturally occurring compound derived from the cannabis plant, particularly hemp. It is used in wellness products, personal care formulations, pharmaceuticals, and nutraceuticals, including oils, capsules, creams, beverages, and supplements. Consumer interest in specialized wellness products, pharmaceutical research, and advances in formulation technologies is creating opportunities across the market. However, regulatory differences, product-quality concerns, and restrictions on specific CBD applications continue to influence commercialization.

Cannabidiol (CBD) Market Key Takeaways

 

  • Market Size in 2025: USD 9.95 billion
  • Market Size in 2026: USD 11.55 billion
  • Projected Market Size by 2034: USD 38.07 billion
  • CAGR (2026–2034): 16.08%
  • Base Year: 2025
  • Forecast Period: 2026–2034
  • Dominant Region: North America
  • North America Market Share in 2025: 42%
  • Fastest-Growing Region: Europe
  • Europe CAGR (2026–2034): 17.8%
  • Fastest-Growing Source Type: Hemp
  • Fastest-Growing Product Type: CBD topicals
  • Leading Application: Pharmaceutical
  • Leading Application Share in 2025: 22%
  • Fastest-Growing Distribution Channel: Online

 

Cannabidiol (CBD) Market Overview

The cannabidiol market covers products made with CBD ingredients for wellness, personal care, pharmaceutical, and other permitted applications. Product categories include CBD oils, topicals, capsules, and specialized formulations designed for different uses. Market participants include hemp cultivators, ingredient suppliers, product manufacturers, laboratories, and pharmaceutical developers.

The industry is shaped by formulation research, ingredient quality, product traceability, and regulatory requirements. CBD's limited water solubility has encouraged research into delivery systems that may improve dissolution and absorption. At the same time, pharmaceutical applications require careful attention to product consistency, dosing, clinical evidence, and applicable approval pathways. Differences in regulations across countries also affect which products manufacturers can develop, market, and distribute.

Cannabidiol (CBD) Market Trends

Shift Toward Advanced CBD Delivery Systems

CBD's poor water solubility is encouraging research into advanced delivery systems, including polymer-based solid dispersions and self-nanoemulsifying formulations. These technologies aim to improve dissolution and oral absorption, helping manufacturers explore more consistent formulations for pharmaceutical and other applications. A 2025 study published in AAPS PharmSciTech reported that polymer-based CBD solid dispersions improved the dissolution rate by up to 4.75 times in laboratory testing, highlighting the potential of formulation technologies to address a key technical challenge.

Shift Toward Pharmaceutical-Grade CBD Formulations

Demand for more reliable therapeutic formulations is directing attention toward purified CBD, controlled dosing, and rigorous manufacturing standards. This approach allows pharmaceutical developers to focus on defined uses and product consistency rather than unsupported health claims. The U.S. Food and Drug Administration (FDA) has approved Epidiolex, a purified CBD oral solution, for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients aged one year and older. This established prescription use illustrates the role of regulatory review and clinical evidence in pharmaceutical CBD applications.

Cannabidiol (CBD) Market Dynamics

Market Drivers

Demand for CBD Testing and Quality-Control Services

Quality concerns surrounding CBD products create demand for laboratory testing that verifies cannabinoid content, purity, and potential contaminants. The FDA has reported discrepancies between the actual and claimed CBD levels in some tested products, highlighting the importance of reliable quality checks. Independent laboratories can analyze CBD oils and cosmetic ingredients before commercial distribution, helping manufacturers assess product consistency and meet applicable safety and labeling requirements. These needs create business opportunities for analytical laboratories, testing providers, and companies offering specialized quality-control services.

Demand for CBD-Based Personal Care Products

Consumer interest in specialized skincare products is encouraging personal care manufacturers to assess CBD for creams, balms, moisturizers, and body-care formulations. In April 2026, the European Commission’s Scientific Committee on Consumer Safety concluded that CBD was considered safe at concentrations up to 0.19% in dermal cosmetic products, subject to the assessment's conditions and limitations. This assessment provides a relevant safety reference for manufacturers evaluating CBD formulations for applicable European markets. The opportunity extends to CBD ingredient suppliers and cosmetic manufacturers that can develop products while meeting local regulatory and product-safety requirements.

Market Restraints

Regulatory Uncertainty and Restrictions on CBD Products

Differences in national regulations create barriers for companies seeking to sell CBD products across multiple markets. Restrictions on food, cosmetics, and non-prescription products can limit product availability and require manufacturers to adjust formulations, labeling, licensing, and distribution practices. These requirements increase compliance complexity and may delay market entry, particularly for businesses seeking to expand across regions with different rules.

Product Quality and Consumer Confidence Concerns

Variations in CBD concentration, product labeling, and testing practices can make it difficult for consumers to assess product reliability. Manufacturers must invest in ingredient verification, contaminant testing, traceability, and accurate product information to address these concerns. Such requirements can increase operational costs, particularly for smaller companies that lack established quality-control systems.

Market Opportunities

Development of Advanced CBD Formulations

Ingredient suppliers, pharmaceutical developers, and formulation specialists can explore revenue opportunities through delivery systems designed to improve CBD dissolution and absorption. Polymer-based dispersions, self-nanoemulsifying systems, and other specialized formulations offer potential routes to differentiate products and address technical limitations. Commercial success will depend on product performance, safety evidence, manufacturing consistency, and compliance with applicable regulations.

Expansion of CBD Testing and Specialized Personal Care Products

Laboratories and quality-control providers can offer cannabinoid analysis, purity testing, and contaminant screening to manufacturers that need reliable product verification. Personal care companies can also evaluate CBD-based topical formulations for markets where these products are permitted. These opportunities create potential business for CBD ingredient suppliers, testing laboratories, and cosmetic manufacturers that prioritize product safety and regulatory compliance.

Cannabidiol (CBD) Market Segmentation Analysis

The cannabidiol market is segmented by source type, product type, application, and distribution channel. Hemp is the fastest-growing source type, CBD topicals lead product-type growth, pharmaceuticals represent the leading application, and online sales are the fastest-growing distribution channel.

By Source Type

The hemp segment is projected to register a CAGR of 15.8% during the forecast period. Hemp-derived CBD serves as an ingredient in wellness products, personal care formulations, and other consumer applications where its use is permitted. Product development in this category depends on sourcing standards, ingredient consistency, and compliance with local requirements.

The marijuana segment is expected to record a CAGR of 14.1% during the forecast period. Marijuana-derived CBD is used in selected therapeutic and specialized wellness applications, subject to applicable laws. Regulatory classification and restrictions on cannabis-derived ingredients remain important considerations for manufacturers operating in this segment.

By Product Type

The CBD oil segment accounted for the largest share of the product-type category, representing 34% of the market in 2025. Its position reflects its use across wellness formulations and other CBD-based products. Product concentration, ingredient quality, labeling, and regulatory compliance remain important factors for manufacturers serving this category.

The CBD topicals segment is projected to register the highest CAGR of 16.9% during the forecast period. Creams, balms, and other topical formulations offer personal care manufacturers a way to explore specialized CBD-based products. Their commercial potential depends on product safety, permitted ingredient concentrations, and market-specific cosmetic regulations.

By Application

The pharmaceutical segment dominated the application category, accounting for 22% of the market in 2025. Its position reflects the use of CBD in specific therapeutic formulations and pharmaceutical research. Clinical evidence, manufacturing controls, and regulatory approval remain central to the development and commercialization of pharmaceutical CBD products.

The topicals segment is projected to register the highest CAGR of 17.1% during the forecast period. Demand for CBD-infused skincare and other topical formulations creates opportunities for cosmetic manufacturers and ingredient suppliers in markets where these applications are permitted. Product development requires appropriate safety assessments and compliance with regional ingredient restrictions.

By Distribution Channel

The online segment is projected to register a CAGR of 16.8% during the forecast period. E-commerce platforms provide access to a wider product selection and convenient purchasing options where CBD sales are legally permitted. Businesses using this channel must also address restrictions on product listings, advertising, labeling, and cross-border distribution.

The offline segment is expected to record a CAGR of 13.1% during the forecast period. Pharmacies, specialty stores, and wellness retailers provide in-person product selection and customer guidance. This channel remains relevant for consumers who prefer physical retail outlets and for businesses operating

Cannabidiol (CBD) Market Future Outlook

The cannabidiol market is projected to expand as companies explore specialized formulations, pharmaceutical applications, personal care products, and permitted online sales. Research into advanced delivery systems may help address technical challenges associated with CBD solubility, while testing and quality-control services remain important for verifying ingredient content and product consistency.

Regional regulations will continue to influence market access and product development. Companies seeking to capitalize on opportunities will need to align formulations with local requirements, maintain reliable sourcing and testing practices, and communicate product information accurately. The market's long-term direction will depend on the combination of consumer demand, scientific evidence, regulatory clarity, and manufacturers' ability to deliver consistent products.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/cannabidiol-market

About Straits Research

Straits Research is a global market intelligence and consulting company that provides business insights, market analysis, and strategic research across multiple industries. The company supports businesses, investors, and decision-makers with industry assessments, competitive analysis, and data-driven insights to help identify market opportunities and inform strategic planning.